Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mucosal immune regulation by high dose vitamin D treatment in Crohn's disease
2013-000971-34Phase 3Completed
- Sponsor
- Jørgen Agnholt
- Start
- Aug 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Crohn's disease comparing High-dose cholecalciferol with Placebo (2 arms). Primary endpoint: Mucosal VDR expression in immune cells. Started Aug 2013; status: completed.
02
Drugs
vitamin d
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2013-000971-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000971-34.